Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Logout MarketXLS
Revance Therapeutics Inc. logo

Revance Therapeutics Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

24.94
 
USD
  
0.39
  
(1.59%)
Optionable: Yes  Market Cap: 2,021 M  90-day average vol: 1,203,022

Previous close: 24.55  Open: 24.74  Bid: 25.42  Ask: 25.42
52 week range    
11.27   
   29.58
Peers   
MNOV / 
JNJ / 
TENX / 
Last updated: Thursday 29th September 2022
48
MarketXLS Rank marketxls
40
Value marketxls
76
Technical marketxls
28
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BIIB

34 B21.6221.3

JNJ

0.0247450 B22.1171.06

MNOV

0 B-10.82.42

TENX

0 B-0.30.7312
News
Financials

RVNC Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues7170006170003830003000003000002620004 M41300015 M78 M
Cost of sales-2 M-2 M-2 M-3 M-3 M-2 M-623000-272000-6 M2 M
Gross operating profit7170006170003830003000003000002620004 M41300013 M56 M
Selling Gen & administrative expense11 M11 M19 M25 M29 M37 M54 M61 M150 M195 M
Research & development expense33 M28 M33 M48 M50 M80 M93 M103 M126 M116 M
Operating income-43 M-38 M-52 M-72 M-79 M-117 M-143 M-164 M-273 M-275 M
floaterest income0000000000
floaterest expense0000000000
Other income net14 M939000-239000-200000-10 M-4 M-913000-502000-721000-698000
Pre-tax Income (EBT)-58 M-52 M-63 M-73 M-89 M-121 M-140 M-159 M-285 M-281 M
Income taxes0000003 M0-3 M0
Net income from total operations-58 M-52 M-63 M-73 M-89 M-121 M-143 M-159 M-282 M-281 M
Minority floaterest0000000000
Total net income-58 M-52 M-63 M-73 M-89 M-121 M-143 M-159 M-282 M-281 M
Preferred dividendsN/A14 MN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-58 M-67 M-63 M-73 M-89 M-121 M-143 M-159 M-282 M-281 M
Depreciation2 M2 M2 M3 M3 M2 M6230002720009 M20 M
Amortization000000006 M14 M
Operating income before depreciation (EBITDA)-28 M-35 M-50 M-70 M-87 M-119 M-138 M-157 M-259 M-255 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-27.20.01-3.24-3.02-3.18-4.01-3.94-3.67-4.86-4.17
Diluted EPS total-27.20.01-3.24-3.02-3.18-4.01-3.94-3.67-4.86-4.17
Call: 1-877-778-8358
Ankur Mohan MarketXLS
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today